Screening molecular markers in early breast cancer of the same pathological types but with different prognoses using Agilent gene chip

Zhou LI; Liang PENG; Shuai HAN; Zonghai HUANG; Fujun SHI; Zhai CAI; Xiuqin LI; Pusheng ZHANG; Huijuan ZHU; Weirong JIN.
Journal of Southern Medical University ; (12): 1483-1488, 2013.
Artículo en Zh | WPRIM | ID: wpr-232769

Documentos relacionados

  1. Archival single-cell genomics reveals persistent subclones during DCIS progression.
  2. Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis.
  3. Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing.
  4. Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breast.
  5. STK3 higher expression association with clinical characteristics in intrinsic subtypes of breast cancer invasive ductal carcinoma patients.
  6. Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes.
  7. Histological and electron microscopic features of the extracellular matrix of invasive breast ductal carcinoma of no special type. Report of 5 cases and literature review.
  8. Aldehyde dehydrogenase-1 positivity is associated with ER negativity in patients with invasive ductal carcinoma of the breast.
  9. ASO Author Reflections: Toward Individualized Management of Heterogenous Mixed Invasive Ductolobular Breast Cancers.
  10. Prognosis and effectiveness of chemotherapy for medullary breast carcinoma.